Category archives for: Business

CEO, President and Secretary of JAKKS PACIFIC INC (U.S.: Nasdaq:JAKK), Berman Stephen G, sells 7,075 shares worth $65,727

According to JAKKS PACIFIC INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 08:12 PM, company CEO, President and Secretary, Berman Stephen G disclosed selling 7,075 shares at a cost of $9.29. At the time of this transaction (Jan 12), this trade was worth $65,727 […]

CEO, President and Secretary of JAKKS PACIFIC INC (U.S.: Nasdaq:JAKK), Berman Stephen G, sells 7,550 shares worth $71,348

According to JAKKS PACIFIC INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 08:12 PM, company CEO, President and Secretary, Berman Stephen G disclosed selling 7,550 shares at a cost of $9.45. At the time of this transaction (Jan 11), this trade was worth $71,348 […]

CEO, President and Secretary of JAKKS PACIFIC INC (U.S.: Nasdaq:JAKK), Berman Stephen G, sells 8,308 shares worth $76,434

According to JAKKS PACIFIC INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 08:12 PM, company CEO, President and Secretary, Berman Stephen G disclosed selling 8,308 shares at a cost of $9.20. At the time of this transaction (Jan 10), this trade was worth $76,434 […]

President and CEO of Dolby Laboratories, Inc. (U.S.: NYSE:DLB), Yeaman Kevin J, sells 34,621 shares worth $3,223,173

According to Dolby Laboratories, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 08:11 PM, company President and CEO, Yeaman Kevin J disclosed selling 34,621 shares at a cost of $93.10. At the time of this transaction (Jan 11), this trade was worth $3,223,173 in […]

SVP, Marketing of TREACE MEDICAL CONCEPTS, INC. (U.S.: Nasdaq:TMCI), Scanlan Sean F., sells 8,838 shares worth $177,846

According to TREACE MEDICAL CONCEPTS, INC.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 08:01 PM, company SVP, Marketing, Scanlan Sean F. disclosed selling 8,838 shares at a cost of $20.12. At the time of this transaction (Jan 11), this trade was worth $177,846 in […]

SVP, Marketing of TREACE MEDICAL CONCEPTS, INC. (U.S.: Nasdaq:TMCI), Scanlan Sean F., sells 38,862 shares worth $783,532

According to TREACE MEDICAL CONCEPTS, INC.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 08:01 PM, company SVP, Marketing, Scanlan Sean F. disclosed selling 38,862 shares at a cost of $20.16. At the time of this transaction (Jan 10), this trade was worth $783,532 in […]

CEO of BIOLIFE SOLUTIONS INC (U.S.: Nasdaq:BLFS), Rice Michael, sells 16,666 shares worth $528,646

According to BIOLIFE SOLUTIONS INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 08:00 PM, company CEO, Rice Michael disclosed selling 16,666 shares at a cost of $31.72. At the time of this transaction (Jan 12), this trade was worth $528,646 in total. As of […]

CEO of BIOLIFE SOLUTIONS INC (U.S.: Nasdaq:BLFS), Rice Michael, sells 16,666 shares worth $513,813

According to BIOLIFE SOLUTIONS INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 08:00 PM, company CEO, Rice Michael disclosed selling 16,666 shares at a cost of $30.83. At the time of this transaction (Jan 10), this trade was worth $513,813 in total. As of […]

Chief Financial Officer of Robinhood Markets, Inc. (U.S.: Nasdaq:HOOD), Warnick Jason, sells 20,000 shares worth $302,508

According to Robinhood Markets, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 07:47 PM, company Chief Financial Officer, Warnick Jason disclosed selling 20,000 shares at a cost of $15.13. At the time of this transaction (Jan 10), this trade was worth $302,508 in total. […]

Chief Executive Officer of Kymera Therapeutics, Inc. (U.S.: Nasdaq:KYMR), Mainolfi Nello, sells 8,612 shares worth $448,551

According to Kymera Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jan 12 07:30 PM, company Chief Executive Officer, Mainolfi Nello disclosed selling 8,612 shares at a cost of $52.08. At the time of this transaction (Jan 12), this trade was worth $448,551 in total. […]

Featured Press Releases

Photo Gallery

Log in